Vectura initiates legal proceedings against GlaxoSmithKline
In response to this, Vectura has filed a patent infringement lawsuit against GSK claiming infringement of Vectura's U.S. Patent No. 8,303,991 in the United States District Court for
Arna Pharma and Slate Run Pharmaceuticals have completed a joint venture (JV) to form a speciality pharmaceutical company in the US focusing on branded products, 505(b)(2) medicines, and specialised generics.
Espada is a wholly-owned subsidiary of Mission Pharmacal Company (Mission) and adds breadth to Mission’s established line of dermatological drug products. Prior to this acquisition, Mission offered prescription